On Invalid Date, Vaccinex (NASDAQ: VCNX) reported Q3 2023 earnings per share (EPS) of -$1.09, up 34.73% year over year. Total Vaccinex earnings for the quarter were -$4.91 million. In the same quarter last year, Vaccinex's earnings per share (EPS) was -$1.67.
As of Q4 2023, Vaccinex's earnings has grown year over year. Vaccinex's earnings in the past year totalled -$22.01 million.
What was VCNX's revenue last quarter?
On Invalid Date, Vaccinex (NASDAQ: VCNX) reported Q3 2023 revenue of $20.00 thousand up 60% year over year. In the same quarter last year, Vaccinex's revenue was $50.00 thousand.
What was VCNX's revenue growth in the past year?
As of Q4 2023, Vaccinex's revenue has grown 1,490% year over year. This is 1,379.42 percentage points higher than the US Biotechnology industry revenue growth rate of 110.58%. Vaccinex's revenue in the past year totalled $795.00 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.